Open-label single-arm phase II trial of sorafenib therapy with drugeluting bead transarterial chemoembolization in patients with unresectable hepatocellular carcinoma: Clinical results

David P. Cosgrove, Diane K. Reyes, Timothy M. Pawlik, Allen L. Feng, Ihab R. Kamel, Jean François H. Geschwind

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Open-label single-arm phase II trial of sorafenib therapy with drugeluting bead transarterial chemoembolization in patients with unresectable hepatocellular carcinoma: Clinical results'. Together they form a unique fingerprint.

Medicine & Life Sciences